IP Library Patent Application 15525061
Patent Application
App. No. 15/525,061

HIGH-AFFINITY IMMUNOPOLYMERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/525,061
Abstract

The present disclosure is directed to high-affinity immunopolymers for use in a variety of immunoassays and other techniques. The immunopolymers comprise a plurality of antibodies, a plurality of coupling proteins, and a plurality of detectable labels. The plurality of antibodies and plurality of coupling proteins are associated by a high-efficiency conjugation moiety, and may be used in highly multiplexed assays. Methods of preparing the high-affinity immunopolymers are provided. Also disclosed are methods of detecting an antigen that include reacting an antigen with a high-affinity immunopolymer of the disclosure. Reagent mixtures and methods for quantitative immunochemical assays are also provided. The mixtures and methods may include the high-affinity immunopolymers disclosed herein.

Claims (31)

1 - 75 . (canceled)

76 . A reagent mixture for calibration of an immunochemical assay, comprising:

a first population and a second population of particles comprising a detectable agent,

wherein the detectable agent is associated with the surface of the first population of particles at a first surface density and is associated with the surface of the second population of particles at a second surface density, and wherein the detectable agent is a cellular antigen or a hapten.

77 . The reagent mixture of claim 76 , wherein the particles are microspheres.

78 . The reagent mixture of claim 76 , further comprising a detectable immunoreagent specific for the detectable agent.

79 . The reagent mixture of claim 78 , wherein the detectable immunoreagent comprises a fluorescent label.

80 . The reagent mixture of claim 78 , wherein the detectable immunoreagent is a high-affinity immunopolymer comprising:

a plurality of antibodies;

a plurality of coupling proteins; and

a plurality of detectable labels;

wherein the plurality of antibodies and the plurality of coupling proteins are associated by a high-efficiency conjugation moiety.

81 . The reagent mixture of claim 76 , wherein the hapten is selected from the group consisting of: a nitrophenyl, a dinitrophenyl, a digoxygenin, a biotin, a Myc tag, a FLAG tag, an HA tag, an S tag, a Streptag, a His tag, a V5 tag, a ReAsh tag, a FlAsh tag, a biotinylation tag, Sfp tag, or a peptide tag.

82 . A method for calibration of an immunochemical assay comprising:

treating a population of cells with a first population and a second population of particles comprising a detectable agent, wherein the detectable agent is associated with the surface of the first population of particles at a first surface density and is associated with the surface of the second population of particles at a second surface density, and wherein the detectable agent is a cellular antigen or a hapten.

83 . The method of claim 82 , wherein the particles are microspheres.

84 . The method of claim 82 , wherein the cells and the particles are also treated with a detectable immunoreagent specific for the detectable agent.

85 . The method of claim 84 , wherein the detectable immunoreagent comprises a fluorescent label.

86 . The method of claim 84 , wherein the detectable immunoreagent is a high-affinity immunopolymer comprising:

a plurality of antibodies;

a plurality of coupling proteins; and

a plurality of detectable labels;

wherein the plurality of antibodies and the plurality of coupling proteins are associated by a high-efficiency conjugation moiety.

87 . The method of claim 84 , wherein the cells and the particles are separately treated with the detectable immunoreagent.

88 . The method of claim 84 , wherein the cells and the particles are jointly treated with the detectable immunoreagent.

89 - 93 . (canceled)

94 . The reagent mixture of claim 76 , wherein the reagent mixture comprises at least three populations of calibrant particles, each population with a different surface density of the detectable agent.

95 . The method of claim 82 , wherein the population of cells is treated with a third population of particles comprising the detectable agent associated with the surface of the third population of particles at a third surface density.

96 . The method of claim 82 , further including the step of detecting the amount of detectable agent in the cells and in the particles.

97 . The method of claim 82 , further including the step of scoring the level of detectable agent in the cells, based on the amount of detectable agent in the different populations of particles.

98 . The method of claim 97 , wherein the scoring step is performed automatically.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2026
From: CELL IDX, INC.
To: LEICA BIOSYSTEMS NEWCASTLE LTD.
Reel/Frame 073410/0342 →
CONFIRMATORY LICENSE Recorded Jun 29, 2021
From: UNIVERSITY OF CHICAGO
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 056707/0130 →